Peripheral arterial disease in patients with chronic obstructive pulmonary disease

International Angiology

Volumn 31, Issue 5, 2012, Pages 444-453

  Pecci, R ^a   De La Fuente Aguado, J ^a   Sanjurjo Rivo, A B ^a   Sanchez Conde, P ^a   Corbacho Abelaira, M D ^a  

^a HOSPITAL POVISA   (Spain)

Author keywords

Ankle brachial index; Peripheral arterial disease; Pulmonary disease, chronic obstructive

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; SPIROMETRY;

AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; ASYMPTOMATIC DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; SPIROMETRY;

EID: 84869839819     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46. (Pubitemid 38807371)
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009) [Internet]. Available at http://www.gold-copd.com/ Guidelineitem.asp?l1=2&l2=1&intId=2003. [cited 2012, Jul 11].
3. Huiart L, Erns P, Suissa S Cardiovascular morbidity and mortality in COPD. Chest 2005;128:2640-6. (Pubitemid 41507622)
4. Curkendall SM, De Luise C, Jones JK, Lanes S. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006;16:63-70. (Pubitemid 41783891)
5. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P Symptoms of chronic bronchitis and the risk of coronary disease Lancet 1996;348:567-72. (Pubitemid 26283887)
6. Hansell AL, Walk JA, Soriano JB What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis Eur Respir J 2003;22:809-14. (Pubitemid 37369571)
7. Engstrom G, Wollmer P, Hedblad B, Juul-Moller S, Valind S, Janzon L Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914", Malmo, Sweden. Circulation 2001;103:3086-91. (Pubitemid 32587856)
8. Calverley PM, Anderson JA, Celli BR, Ferguson GT, Jenkins C, Jones PW. TORCH. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease NEJM 2007;356:775-89. (Pubitemid 46294610)
9. Anthonisen NR, Connett JE, Enright PL, Manfreda J Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study Am J Respir Crit Care Med 2002;166:333-9. (Pubitemid 34864422)
10. Ramos R, Quesada M, Solanas P, Subirana I, Sala J, Vila J et al. Prevalence of Symptomatic and Asymptomatic Peripheral Arterial Disease and the Value of the Ankle-brachial Index to Stratify Cardiovascular Risk. Eur J Vasc Endovasc Surg 2009;38:309-9.
11. Diehm C, Allenberg J, Pittrow D, Mahn M, Tepohl G, Haberl R et al. Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease. Circulation 2009;120:2053-61.
12. Blanes-Mompó J, Plaza-Martinez A, Zarajoco-Garcia J, Gallego-Torromé LM, Ortiz-Monzon E. Evolución Natural de la Claudicación Intermitente. Angiología 2003;55:S20-37.
13. Boussuges A, Rossi P, Gouitaa M, Cara Ñ Alterations in the peripheral circulation in COPD patients. Clin Physiol Funct Imaging 2007;27:284-90. (Pubitemid 47278523)
14. Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y, Yamane K et al. Airflow Limitation in Smokers Is Associated with Subclinical Atherosclerosis. Am J Respir Crit Care Med 2009;179:35-40.
15. Ozer T, Altin R, Ugurbas S, Ozer Y, Mahmutyazicioglu K, Kart L. Color Doppler evaluation of the ocular arterial flow changes in chronic obstructive pulmonary disease. Eur J Radiol 2006;57:63-8. (Pubitemid 43075411)
16. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery C et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med 2007;175:1259-65. (Pubitemid 46905751)
17. Mills N, Miller J, Anand A. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008;63:306-11. (Pubitemid 351497941)
18. Prignot J. Quantification and chemical markers of tobacco-exposure. Eur J Respir Dis 1987;70:1-7. (Pubitemid 17218524)
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) Hypertension 2003;42:1206-52. (Pubitemid 37553153)
20. Asociatiom American Diabetes. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010;33:S62-S69.
21. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Circulation. 2004;110:227-239.)
22. 2002;106:3143-373.
23. Expert Panel on the Identification Evaluation, and Treatment of Overweight in Adults. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults:Executive Summary. Am J Clin Nutr 1998;68:899-917.
24. Leng GC, Fowkers FG The Edinburgh claudication questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101e-9.
25. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2007;28:2375-414.
26. Al-Qaisi M, Note DM, King DH, Kaddoura S. Ankle Brachial Pressure Index (ABPI): An update for practitioners. Vasc Health Risk Manag 2009;5:833-41.
27. Manzano L, García-Díazb JD, Gómez-Cerezo J, Mateos J, Del Valle FJ, Medina-Asensio J, et al. Valor de la determinación del índice tobillo-brazo en pacientes de riesgo vascular sin enfermedad aterotrombótica conocida: estudio VITAMIN. Rev Esp Cardiol 2006;59:662-70.
28. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner J, Creager M, Olin J et al. Treatment in Primary Care Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care. JAMA 2001;286:1317-24. (Pubitemid 33015522)
29. Finkelstein J, Cha E, Scharf SM Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009;4:337-49.
30. Castagna O, Boussuges A, Nussbaum E, Marqueste L, Brisswalter J. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur j Cardiovasc Prev Rehabil 2008;15:270-7.
31. Lucas-Ramos P, Izquierdo-Alonso JL, Rodríguez-González Moro JM, Bellón-Cano JM, Ancochea-Bermúdez J, Calle-Rubio M et al. Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE Study. Arch Bronconeumol 2008;238:233-8. (Pubitemid 351863573)
32. Mc Ghan R, Radcliff T, Fish R, Sutherland R. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007;132:1748-55.
33. Antonelli-Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B et al. Co-Morbidity contributes to predict mortality of patients with COPD. Eur Respir J 1997;10:2794-800. (Pubitemid 28052790)
34. Graham Barr R, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba F et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD Am J Med 2009;122:348-55.
35. Stein R, Hriljac I, Halperin J, Gustavson S, Teodorescu V, Olin J. Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease. Vasc Med 2006;11:29-33.
36. Mourad JJ, Cacoub P, Collet JP, Becker F, Pinel J, Huet D et al. Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD. J Vasc Surg 2009;50:572-80.
37. Nuñez D, Morillas P, Quiles J, Cordero A, Guindo J, Soria F et al. Usefulness of an Abnormal Ankle-Brachial Index for Detecting Multivessel Coronary Disease in Patients With Acute Coronary Syndrome. Rev Esp Cardiol 2010;63:54-9.
38. Zheng L, Li J, Hu D, Luo Y, Li X, Xu Y et al. Association of low ankle-brachial index with mortality in patients with ischemic heart disease. J Atheroscler Thromb 2010;17:759-67.
39. Sin DD, Paul Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-9.
40. Resnick H, Lindsay R, McGrae McDermott M, Devereux R, Jones K, Fabsitz R et al. Relationship of high and low Ankle Brachial Index to all-cause and cardiovascular disease mortality. The Strong Heart Study. Circulation 2004;109:733-9.